Cowen and Company’s Humacyte Inc Warrant HUMAW Stock Holding History

Cowen and Company’s Portfolio HUMAW Stock Details HUMAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-49,724	Closed	-$89.3K	–	156
2024 Q3	$89.3K	Sell	49,724 -45,229	-48%	-$99.7K	﹤0.01%	294
2024 Q2	$132K	Sell	94,953 -92,260	-49%	-$114K	﹤0.01%	244
2024 Q1	$112K	Buy	+187,213	New	+$116K	﹤0.01%	284
2021 Q3	–	Sell	-24,663	Closed	-$69K	–	650
2021 Q2	$69K	Sell	24,663 -142,862	-85%	-$379K	﹤0.01%	371
2021 Q1	$487K	Buy	167,525 +122,525	+272%	+$290K	0.03%	192
2020 Q4	$52K	Buy	+45,000	New	+$42.5K	﹤0.01%	267

Other funds holding HUMAW

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Cowen and Company's HUMAW Position: Q4 2024 in Review

Cowen and Company sold out of Humacyte Inc Warrant (HUMAW) in Q4 2024, closing a stake of 49,724 shares — an estimated $89.3K sold.

Cowen and Company first reported a position in HUMAW in Q4 2020 and held it in 6 quarters. The position peaked at $487K in Q1 2021. 5 funds tracked by Wall St. Rank hold HUMAW as of Q4 2024.

Cowen and Company reported no remaining Humacyte Inc Warrant position as of Q4 2024 after selling out during the quarter.
Cowen and Company sold 49,724 Humacyte Inc Warrant shares in Q4 2024, an estimated $89.3K.
Cowen and Company first reported a position in Humacyte Inc Warrant in Q4 2020 and held it in 6 quarters.
Cowen and Company's Humacyte Inc Warrant position peaked at $487K in Q1 2021.
5 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.